Press "Enter" to skip to content

New patent for ARIAD drug ICLUSIG

0
Copyright © DrugPatentWatch. Originally published at New patent for ARIAD drug ICLUSIG

Annual Drug Patent Expirations for ICLUSIG
Annual Drug Patent Expirations for ICLUSIG

Iclusig is a drug marketed by Ariad and is included in one NDA. There are three patents protecting this drug.

This drug has seventy-eight patent family members in twenty-three countries.

The generic ingredient in ICLUSIG is ponatinib hydrochloride. Additional details are available on the ponatinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for ARIAD drug ICLUSIG
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions